{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T16:53:42Z","timestamp":1772556822453,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T00:00:00Z","timestamp":1552867200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010135","name":"Finska L\u00e4kares\u00e4llskapet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010135","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010119","name":"Stiftelsen Dorothea Olivia, Karl Walter och Jarl Walter Perkl\u00e9ns Minne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010119","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006706","name":"Tampereen Tuberkuloosis\u00e4\u00e4ti\u00d6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006706","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12879-019-3890-x","type":"journal-article","created":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T13:03:04Z","timestamp":1552914184000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Epidemiology and outcome of HIV patients in Finland co-infected with tuberculosis 1998\u20132015"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5866-9634","authenticated-orcid":false,"given":"Ville","family":"Holmberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Soini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pia","family":"Kivel\u00e4","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jukka","family":"Ollgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matti","family":"Ristola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,18]]},"reference":[{"key":"3890_CR1","unstructured":"WHO. Global Tuberculosis Report. 2016."},{"key":"3890_CR2","doi-asserted-by":"crossref","unstructured":"Dheda K, Barry CE, Maartens G. Tuberculosis. Lancet. 2015.","DOI":"10.1016\/S0140-6736(15)00151-8"},{"issue":"12","key":"3890_CR3","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1097\/QAD.0b013e328348fafd","volume":"25","author":"A Kruk","year":"2011","unstructured":"Kruk A, Bannister W, Podlekareva DN, Chentsova NP, Rakhmanova AG, Horban A, et al. Tuberculosis among HIV-positive patients across Europe: changes over time and risk factors. AIDS. 2011;25(12):1505\u201313.","journal-title":"AIDS."},{"issue":"1","key":"3890_CR4","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1086\/510080","volume":"44","author":"L Elzi","year":"2007","unstructured":"Elzi L, Schlegel M, Weber R, Hirschel B, Cavassini M, Schmid P, et al. Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission. Clin Infect Dis. 2007;44(1):94\u2013102.","journal-title":"Clin Infect Dis"},{"issue":"18","key":"3890_CR5","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1097\/QAD.0b013e3283320dfd","volume":"23","author":"AD Grant","year":"2009","unstructured":"Grant AD, Bansi L, Ainsworth J, Anderson J, Delpech V, Easterbrook P, et al. Tuberculosis among people with HIV infection in the United Kingdom: opportunities for prevention? AIDS. 2009;23(18):2507\u201315.","journal-title":"AIDS."},{"issue":"1","key":"3890_CR6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/QAI.0b013e3182255dc2","volume":"58","author":"W Worodria","year":"2011","unstructured":"Worodria W, Massinga-Loembe M, Mazakpwe D, Luzinda K, Menten J, Van Leth F, et al. Incidence and predictors of mortality and the effect of tuberculosis immune reconstitution inflammatory syndrome in a cohort of TB\/HIV patients commencing antiretroviral therapy. J Acquir Immune Defic Syndr. 2011;58(1):32\u20137.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"3890_CR7","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1183\/09031936.00138712","volume":"43","author":"DN Podlekareva","year":"2014","unstructured":"Podlekareva DN, Panteleev AM, Grint D, Post FA, Miro JM, Bruyand M, et al. Short- and long-term mortality and causes of death in HIV\/tuberculosis patients in Europe. Eur Respir J. 2014;43(1):166\u201377.","journal-title":"Eur Respir J"},{"key":"3890_CR8","first-page":"CD000171","volume":"1","author":"C Akolo","year":"2010","unstructured":"Akolo C, Adetifa I, Shepperd S, Volmink J. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev. 2010;1:CD000171.","journal-title":"Cochrane Database Syst Rev"},{"key":"3890_CR9","unstructured":"WHO. Guidelines on the management of latent tuberculosis infection. 2015."},{"key":"3890_CR10","unstructured":"Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV medicine Association of the Infectious Diseases Society of America. p. F1\u2013F29. Accessed on 28 Jan 2016. Available at \n                    http:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/adult_oi.pdf"},{"key":"3890_CR11","unstructured":"European AIDS Clinical Society Guidelines Version 8.1. 2016."},{"issue":"9","key":"3890_CR12","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/j.1468-1293.2011.00954.x","volume":"12","author":"AL Pozniak","year":"2011","unstructured":"Pozniak AL, Coyne KM, Miller RF, Lipman MC, Freedman AR, Ormerod LP, et al. British HIV Association guidelines for the treatment of TB\/HIV coinfection 2011. HIV Med. 2011;12(9):517\u201324.","journal-title":"HIV Med"},{"issue":"4","key":"3890_CR13","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1128\/JCM.35.4.907-914.1997","volume":"35","author":"J Kamerbeek","year":"1997","unstructured":"Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol. 1997;35(4):907\u201314.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"3890_CR14","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.meegid.2012.02.004","volume":"12","author":"C Demay","year":"2012","unstructured":"Demay C, Liens B, Burguiere T, Hill V, Couvin D, Millet J, et al. SITVITWEB--a publicly available international multimarker database for studying Mycobacterium tuberculosis genetic diversity and molecular epidemiology. Infect Genet Evol. 2012;12(4):755\u201366.","journal-title":"Infect Genet Evol"},{"key":"3890_CR15","unstructured":"SITVIT WEB. Accessed on 4 Oct 2016. Available at \n                    http:\/\/www.pasteur-guadeloupe.fr:8081\/SITVIT_ONLINE\/\n                    \n                  ."},{"issue":"4","key":"3890_CR16","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1097\/EDE.0b013e31821b5332","volume":"22","author":"JD Kowalska","year":"2011","unstructured":"Kowalska JD, Friis-Moller N, Kirk O, Bannister W, Mocroft A, Sabin C, et al. The coding causes of death in HIV (CoDe) project: initial results and evaluation of methodology. Epidemiology. 2011;22(4):516\u201323.","journal-title":"Epidemiology."},{"key":"3890_CR17","unstructured":"Miles to go - Global AIDS update 2018 \n                    http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/miles-to-go_en.pdf\n                    \n                  ."},{"issue":"4","key":"3890_CR18","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1093\/eurpub\/ckl252","volume":"17","author":"P Kivela","year":"2007","unstructured":"Kivela P, Krol A, Simola S, Vaattovaara M, Tuomola P, Brummer-Korvenkontio H, et al. HIV outbreak among injecting drug users in the Helsinki region: social and geographical pockets. Eur J Pub Health. 2007;17(4):381\u20136.","journal-title":"Eur J Pub Health"},{"issue":"4","key":"3890_CR19","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1097\/00002030-199704000-00008","volume":"11","author":"C Whalen","year":"1997","unstructured":"Whalen C, Horsburgh CR Jr, Hom D, Lahart C, Simberkoff M, Ellner J. Site of disease and opportunistic infection predict survival in HIV-associated tuberculosis. AIDS. 1997;11(4):455\u201360.","journal-title":"AIDS."},{"issue":"18","key":"3890_CR20","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1097\/00002030-199818000-00014","volume":"12","author":"A Mwinga","year":"1998","unstructured":"Mwinga A, Hosp M, Godfrey-Faussett P, Quigley M, Mwaba P, Mugala BN, et al. Twice weekly tuberculosis preventive therapy in HIV infection in Zambia. AIDS. 1998;12(18):2447\u201357.","journal-title":"AIDS."},{"key":"3890_CR21","doi-asserted-by":"crossref","unstructured":"Pape JW, Jean SS, Ho JL, Hafner A, Johnson WD, Jr. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet. 1993;342(8866):268\u2013272.","DOI":"10.1016\/0140-6736(93)91817-6"},{"issue":"9","key":"3890_CR22","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1056\/NEJMoa1507198","volume":"373","author":"C Danel","year":"2015","unstructured":"Danel C, Moh R, Gabillard D, Badje A, Le Carrou J, Ouassa T, et al. A trial of early Antiretrovirals and isoniazid preventive therapy in Africa. N Engl J Med. 2015;373(9):808\u201322.","journal-title":"N Engl J Med"},{"issue":"11","key":"3890_CR23","doi-asserted-by":"publisher","first-page":"e1080","DOI":"10.1016\/S2214-109X(17)30372-8","volume":"5","author":"A Badje","year":"2017","unstructured":"Badje A, Moh R, Gabillard D, Guehi C, Kabran M, Ntakpe JB, et al. Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial. Lancet Glob Health. 2017;5(11):e1080\u2013e9.","journal-title":"Lancet Glob Health"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3890-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-3890-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3890-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:05:30Z","timestamp":1584403530000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-3890-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,18]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3890"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-3890-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,18]]},"assertion":[{"value":"1 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study has been approved by the Ethical committee of the Helsinki University Hospital and follows the principles of the Declaration of Helsinki. As this was a retrospective register study consent from the patients was not needed.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"264"}}